Table of Contents
ISRN Microbiology
Volume 2011, Article ID 318348, 5 pages
http://dx.doi.org/10.5402/2011/318348
Research Article

Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital

1Department of Microbiology, Government Medical College, Anantapur 515001, India
2Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa 516003, India

Received 25 August 2011; Accepted 19 October 2011

Academic Editors: A. Netrusov and P. Zunino

Copyright © 2011 Vemula Sarojamma and Vadde Ramakrishna. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Livermore, “Bacterial resistance: origins, epidemiology, and impact,” Clinical Infectious Diseases, vol. 36, supplement 1, pp. S11–S23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Pitout and K. B. Laupland, “Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern,” The Lancet Infectious Diseases, vol. 8, no. 3, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Steward, D. Wallace, S. K. Hubert et al., “Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories,” Diagnostic Microbiology and Infectious Disease, vol. 38, no. 1, pp. 59–67, 2000. View at Publisher · View at Google Scholar
  5. V. Gupta, “An update on newer β-lactamases,” Indian Journal of Medical Research, vol. 126, no. 5, pp. 417–427, 2007. View at Google Scholar · View at Scopus
  6. D. M. Livermore, R. Canton, M. Gniadkowski et al., “CTX-M: changing the face of ESBLs in Europe,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 165–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Stürenburg and D. Mack, “Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control,” Journal of Infection, vol. 47, no. 4, pp. 273–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Perez, A. Endimiani, K. M. Hujer, and R. A. Bonomo, “The continuing challenge of ESBLs,” Current Opinion in Pharmacology, vol. 7, no. 5, pp. 459–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. D.V. Romero, T. P. Padilla, A. H. Hernández et al., “Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases,” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 4, pp. 433–437, 2007. View at Publisher · View at Google Scholar
  10. K. C. Kuo, Y. H. Shen, and K. P. Hwang, “Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 40, no. 3, pp. 248–254, 2007. View at Google Scholar · View at Scopus
  11. S. Hoşoǧlu, S. Gundes, F. Kolayli et al., “Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals,” Indian Journal of Medical Microbiology, vol. 25, no. 4, pp. 346–350, 2007. View at Google Scholar
  12. Y. Messai, H. Iabadene, T. Benhassine et al., “Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria),” Pathologie Biologie, vol. 56, no. 5, pp. 319–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. A. Jacoby and L. S. Munoz-Price, “The new β-lactamases,” The New England Journal of Medicine, vol. 352, no. 4, pp. 380–391, 2005. View at Google Scholar · View at Scopus
  14. Clinical Laboratory Standards Institute CLSI, “Performance standards for antimicrobial susceptibility testing,” in Proceedings of the 16th International Supplement (M100-S16), National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2006.
  15. W. Washington Jr., A. Stephan, J. William et al., Eds., Koneman’s Color Atlas and Text book of Diagnostic Microbiology, Lipponcott Williams & Wilkins, 6th edition, 2006.
  16. A. W. Bauer, H. Truck, and J. C. Sherries, “Antibiotic Susceptibility testing by standardized single disc method,” American Journal of Clinical Pathology, vol. 45, pp. 493–496, 1990. View at Google Scholar
  17. National Committee for Clinical Laboratory Standards NCCLS, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A5 and informational Supplement M100-S10, National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2000.
  18. V. Jarlier, M. H. Nicolas, G. Fournier, and A. Philippon, “Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns,” Reviews of Infectious Diseases, vol. 10, no. 4, pp. 867–878, 1988. View at Google Scholar · View at Scopus
  19. J. B. Hansotia, V. Agarwal, A. A. Pathak, and A. M. Saoji, “Extended spectrum β-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India,” Indian Journal of Medical Research, vol. 105, pp. 158–161, 1997. View at Google Scholar · View at Scopus
  20. V. Manchanda, N. P. Singh, R. Goyal, A. Kumar, and S. S. Thukral, “Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases,” Indian Journal of Medical Research, vol. 122, no. 4, pp. 330–337, 2005. View at Google Scholar · View at Scopus
  21. C. Rodrigues, P. Joshi, S. H. Jani, M. Alphonse, R. Radhakrishnan, and A. Mehta, “Detection of β-lactamases in nosocomial gram negative clinical isolates,” Indian Journal of Medical Microbiology, vol. 22, no. 4, pp. 247–250, 2004. View at Google Scholar
  22. P. Lal, A. Kapil, B. K. Das, and S. Sood, “Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital,” Indian Journal of Medical Research, vol. 125, no. 2, pp. 173–178, 2007. View at Google Scholar · View at Scopus
  23. S. Ananthan and A. Subha, “Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli,” Indian Journal of Medical Microbiology, vol. 23, no. 1, pp. 20–23, 2005. View at Google Scholar · View at Scopus
  24. I. Shukla, R. Tiwari, and M. Agrawal, “Prevalence of extended spectrum β-lactamasee producing Klebsiella pneumoniae in a tertiary care hospital,” Indian Journal of Medical Microbiology, vol. 22, no. 2, pp. 87–91, 2004. View at Google Scholar · View at Scopus
  25. C. L. Emery and L. A. Weymouth, “Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center,” Journal of Clinical Microbiology, vol. 35, no. 8, pp. 2061–2067, 1997. View at Google Scholar · View at Scopus
  26. S. Kevin, S. Paul, X. Xiaqqin et al., “Extended spectrum beta lactamase producing Klebsiella pneumoniae strain casing nosocomial outbreaks of infection in the United Kingdom,” Journal of Clinical Microbiology, vol. 36, pp. 3105–3110, 1995. View at Google Scholar
  27. V. Gupta, N. Singla, and J. Chander, “Detection of ESBLs using third and fourth generation cephalosporins in double disc synergy test,” Indian Journal of Medical Research, vol. 126, no. 5, pp. 486–487, 2007. View at Google Scholar · View at Scopus
  28. J. C. Lucet, D. Decré, A. Fichelle et al., “Control of a prolonged outbreak of extended-spectrum β-lactamase- producing Enterobacteriaceae in a university hospital,” Clinical Infectious Diseases, vol. 29, no. 6, pp. 1411–1418, 1999. View at Publisher · View at Google Scholar
  29. S. T. Supriya, V. J. Suresh, A. Sarfraz, and H. Umesh, “Evaluation of extended spectrum beta lactamase in urinary isolates,” Indian Journal of Medical Research, vol. 120, no. 6, pp. 553–556, 2004. View at Google Scholar · View at Scopus
  30. G. Saurina, J. M. Quale, V. M. Manikal, E. Oydna, and D. Landman, “Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns,” Journal of Antimicrobial Chemotherapy, vol. 45, no. 6, pp. 895–898, 2000. View at Google Scholar
  31. D. Mathai, M. T. Lewis, K. C. Kugler, M. A. Pfaller, and R. N. Jones, “Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the SENTRY antimicrobial surveillance program (North America, 1998),” Diagnostic Microbiology and Infectious Disease, vol. 39, no. 2, pp. 105–116, 2001. View at Publisher · View at Google Scholar
  32. P. L. Winokur, R. Canton, J. M. Casellas, and N. Legakis, “Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region,” Clinical Infectious Diseases, vol. 32, supplement 10, pp. S94–S103, 2001. View at Google Scholar · View at Scopus
  33. L. Cordero, R. Rau, D. Taylor, and L. W. Ayers, “Enteric gram-negative bacilli bloodstream infections: 17 Years' experience in a neonatal intensive care unit,” American Journal of Infection Control, vol. 32, no. 4, pp. 189–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Xiong, D. Zhu, Y. Zhang, and F. Wang, “Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates,” Zhonghua Yi Xue Za Zhi, vol. 82, no. 21, pp. 1476–1479, 2002. View at Google Scholar · View at Scopus
  35. H. Goossens, “MYSTIC program: summary of European data from 1997 to 2000,” Diagnostic Microbiology and Infectious Disease, vol. 41, no. 4, pp. 183–189, 2001. View at Publisher · View at Google Scholar
  36. S. Singhal, T. Mathur, S. Khan et al., “Evaluation of methods for Amp C β-lactamase in gram negative clinical isolates from tertiary care hospitals,” Indian Journal of Medical Microbiology, vol. 23, no. 2, pp. 120–124, 2005. View at Google Scholar
  37. C. M. C. Lalitha, “Vellore Manual on antimicrobial susceptibility testing,” 2005. View at Google Scholar
  38. V. Manchanda and N. P. Singh, “Occurrence and detection of Amp C β-lactamases among Gram-negative clinical isolates using a modified tree-dimensional test at Guru Tegh Bahadur hospital, Delhi, India,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 2, pp. 415–418, 2003. View at Publisher · View at Google Scholar · View at Scopus